BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 32372582)

  • 1. [Ethics of organized cancer screening in France].
    Moutel G; Darquy S; Jullian O; Duchange N
    Sante Publique; 2019; S2(HS2):67-74. PubMed ID: 32372582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Not Available].
    Moutel G; Darquy S; Jullian O; Duchange N
    Sante Publique; 2020; 2(HS2):67-74. PubMed ID: 35724230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ethical considerations in the evolution of organised cancer screening programs].
    Jullian O; Darquy S; Moutel G; Duchange N
    Rev Prat; 2019 Jan; 69(1):107-109. PubMed ID: 30983298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Organized screening of colorectal cancer in France. System of care and professional logistics].
    Herbert C; Launoy G
    Sante Publique; 1999 Dec; 11(4):391-407. PubMed ID: 10798168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low participation in organized colorectal cancer screening in France: underlying ethical issues.
    Moutel G; Duchange N; Lièvre A; Orgerie MB; Jullian O; Sancho-Garnier H; Darquy S
    Eur J Cancer Prev; 2019 Jan; 28(1):27-32. PubMed ID: 29176350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Methods to increase participation in cancer screening programmes].
    Giorgi Rossi P; Camilloni L; Cogo C; Federici A; Ferroni E; Furnari G; Giordano L; Grazzini G; Iossa A; Jimenez B; Palazzi M; Palazzo F; Spadea T; Senore C; Borgia P; Guasticchi G
    Epidemiol Prev; 2012 Jan; 36(1 Suppl 1):1-104. PubMed ID: 22418841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organized colorectal cancer screening].
    Rouëssé J; Sancho-Garnier H;
    Bull Acad Natl Med; 2014 Feb; 198(2):387-99. PubMed ID: 26263711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National organized screening programs for breast, colorectal, and cervical cancer reduce socioeconomic disparities, but it is not enough.
    Sterpetti AV; Gabriele R; Iannone I; Dimarzo L; Borrelli V
    Cancer; 2024 Jul; 130(13):2395-2397. PubMed ID: 38642368
    [No Abstract]   [Full Text] [Related]  

  • 9. Key indicators of organized cancer screening programs: Results from a Delphi study.
    Csanádi M; de Kok IM; Heijnsdijk EA; Anttila A; Heinävaara S; Pitter JG; Széles G; Ivanuš U; Priaulx J; Veerus P; Senore C; Koning HJ; Vokó Z
    J Med Screen; 2019 Sep; 26(3):120-126. PubMed ID: 30621498
    [No Abstract]   [Full Text] [Related]  

  • 10. Implementation and organization of cancer screening in France.
    Hamers FF; Assogba FAG; Rogel A
    Int J Cancer; 2018 Dec; 143(12):3281. PubMed ID: 29943827
    [No Abstract]   [Full Text] [Related]  

  • 11. [French national cancer screening programs: What does the future hold?].
    de Bels F; Barré S; Catajar N; Le Bail M
    Rev Prat; 2019 Jan; 69(1):102-106. PubMed ID: 30983297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diffusion of screening programmes in Italy, year 2010].
    Zappa M; Dardanoni G; Giorgi Rossi P; Grazzini G; Naldoni C; Paci E; Pirola ME; Pizzuti R; Segnan N; Zorzi M; Federici A
    Epidemiol Prev; 2012; 36(6 Suppl 1):3-7. PubMed ID: 23293267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Socioeconomic and healthcare use-related determinants of cervical, breast and colorectal cancer screening practice in the French West Indies.
    Menvielle G; Dugas J; Richard JB; Luce D
    Eur J Cancer Prev; 2018 May; 27(3):269-273. PubMed ID: 27824663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical issues in colorectal cancer screening.
    van Dam L; Bretthauer M
    Best Pract Res Clin Gastroenterol; 2014 Apr; 28(2):315-26. PubMed ID: 24810192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Screening in the Coronavirus Pandemic Era: Adjusting to a New Situation.
    Basu P; Alhomoud S; Taghavi K; Carvalho AL; Lucas E; Baussano I
    JCO Glob Oncol; 2021 Mar; 7():416-424. PubMed ID: 33784177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a health systems approach to identify barriers to population-based cervical and colorectal cancer screening programmes in six European countries.
    Turnbull E; Priaulx J; de Kok IMCM; Lansdorp-Vogelaar I; Anttila A; Sarkeala T; Senore C; Segnan N; Csanádi M; Pitter J; Novak Mlakar D; Ivanus U; Veerus P; de Koning HJ; McKee M
    Health Policy; 2018 Nov; 122(11):1206-1211. PubMed ID: 30170757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Creating favorable conditions for organized screening of cervical cancer].
    Baudier F
    Sante Publique; 2000 May; 12 Spec No():5-10. PubMed ID: 10989624
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cancer screening programme in health care workers].
    Pisati G; Cerri S; Marinelli M; Tedeschi B; Valsecchi E
    G Ital Med Lav Ergon; 2011; 33(2 Suppl):57-60. PubMed ID: 22187927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based organized cervical cancer screening pilot program in France.
    Hamers FF; Duport N; Beltzer N
    Eur J Cancer Prev; 2018 Sep; 27(5):486-492. PubMed ID: 28362653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in Screening Abnormality Rates and Follow-Up of Breast, Cervical and Colorectal Cancer Screening within the PROSPR Consortium.
    Tosteson AN; Beaber EF; Tiro J; Kim J; McCarthy AM; Quinn VP; Doria-Rose VP; Wheeler CM; Barlow WE; Bronson M; Garcia M; Corley DA; Haas JS; Halm EA; Kamineni A; Rutter CM; Tosteson TD; Trentham-Dietz A; Weaver DL;
    J Gen Intern Med; 2016 Apr; 31(4):372-9. PubMed ID: 26658934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.